Director, SEC Reporting And SOX

CA, United States

Job description

Attention recruitment agencies: All agency inquiries are vetted through 4DMT’s internal Talent Acquisition team. No unsolicited resumes will be accepted. Agencies must be expressly engaged by the 4DMT Talent Acquisition team on any requisition. Agencies reaching out directly to hiring managers will not be tolerated and doing so may impact your ability to work with 4DMT in the future.

4DMT is a clinical-stage biotherapeutics company harnessing the power of directed evolution for targeted genetic medicines. We seek to unlock the full potential of gene therapy using our platform, Therapeutic Vector Evolution (TVE), which combines the power of directed evolution with our approximately one billion synthetic AAV capsid-derived sequences to invent evolved vectors for use in our products. We believe key features of our targeted and evolved vectors will help us create targeted product candidates with improved therapeutic profiles. These profiles will allow us to treat a broad range of large market diseases, unlike most current genetic medicines that generally focus on rare or small market diseases.  

We have built a deep portfolio of AVV-based gene therapy product candidates, with five product candidates in clinical trials: 4D-150 for the treatment of wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME), 4D-710 for the treatment of cystic fibrosis lung disease, 4D-310 for the treatment of Fabry disease cardiomyopathy, 4D-125 for the treatment of X-linked retinitis pigmentosa (XLRP), and 4D-110 for the treatment of choroideremia. In addition, we have two product candidates in preclinical studies: 4D-175 for geographic atrophy (GA) and 4D-725 for alpha-1 antitrypsin deficiency.

To-date, we have demonstrated clinical proof-of-concept for three evolved vectors in three therapeutic areas and routes of administration with five products and patient populations. We believe this validates the power of our directed evolution platform for discovering superior vectors compared to wildtype viral vectors. We have built a robust and efficient product engine with 6 open Investigational New Drug Applications (INDs) in the U.S., 1 IND in Taiwan, and 1 Clinical Trial Approval (CTA) in Australia. We believe we are positioned to create, develop, manufacture and, if approved, effectively commercialize targeted genetic medicines that could transform the lives of patients suffering from debilitating diseases.

In addition to TVE, our technology includes a robust AAV manufacturing platform and onsite manufacturing facility that allows us to rapidly produce and test research grade material and scale up to GMP clinical material. This internal capability and close collaboration between our R&D and Manufacturing teams has greatly accelerated the pace of discovery at 4DMT.

Company Differentiators: 

•    Fully integrated clinical-phase company with internal manufacturing
•    Demonstrated ability to move rapidly from idea to IND
•    Five candidate products in the clinic and two declared pre-clinical programs
•    Robust technology and IP foundation, including our TVE and manufacturing platforms
•    Initial product safety and efficacy data substantiates the value of our platforms
•    Opportunities to expand to other indications and modalities within genetic medicine

The Director of SEC Reporting and SOX will lead the SEC reporting and the SOX program. This is a highly visible role that offers the opportunity to work with various Finance functions within the Company, including Accounting, FP&A, Investor Relations, Treasury, Stock Administration, and Corporate Tax, as well as HR, Legal, and various operational functions, which will allow you to gain a strong understanding of the Company’s business and operations. 

The ideal candidate has strong knowledge of US GAAP and SOX 404 compliance requirements and biotech industry experience.

RESPONSIBILITIES:  

  • Manage the SEC financial reporting process, including the preparation of the Company’s SEC filings (including Forms 10-K, 10-Q, 8-K, and various other filings), working closely with other functions as needed and ensuring accurate and timely submissions to regulatory authorities
  • Prepare financial statements (including a statement of cash flows), EPS calculation, footnotes, MD&A, accounting memos, US GAAP Disclosure Checklist, and disclosure support
  • Proactively research industry reporting trends and perform benchmarking to make recommendations to improve and strengthen the Company’s SEC filings
  • Manage accounting for stock-based compensation in compliance with ASC 718, including valuation assumptions and preparation of journal entry
  • Coordinate with Legal, Finance, Investor Relations, and other teams with the Company to prepare SEC Filings and lead Disclosure committee meetings
  • Manage SOX program in collaboration with the Company’s third-party service provider, including risk assessment, design assessment, walkthroughs, documentation, testing of internal controls and ITGCs in FloQast
  • Work in partnership with control owners and business leaders across the Company to identify, develop, recommend, and implement appropriate control changes that may result from business changes, non-routine transactions, or system implementations
  • Monitor management’s remediation efforts to closure, including review of supporting evidence
  • Act as the primary point of contact for internal and external auditors during the audit process, providing support and documentation as required for assigned areas
  • Other projects and responsibilities may be added at the manager’s discretion
  • Manage workload distribution, prioritize tasks, and ensure deadlines are met effectively.

QUALIFICATIONS: 

Education: 

  • Bachelor’s degree in Accounting or related field
  • CPA

Experience: 

  • 12 + years of relevant experience with a mix of Big 4 public accounting and a compliance role in the biotech industry

Skills: 

  • Advanced understanding of SEC Reporting and SOX 404
  • Excellent Excel spreadsheet skills and proficiency with other Microsoft Office products (Word, PowerPoint, etc.)
  • Hands-on experience with SEC filing systems such as Active Disclosure
  • Strong analytical and problem-solving skills, with the ability to interpret complex financial data and trends
  • Excellent communication and interpersonal skills, with the ability to collaborate effectively across functional teams
  • Strong attention to detail, decision-making, problem-solving, project management, and organizational skills
  • Ability to quickly learn and utilize reporting and other management systems and tools.

Base salary compensation range $210,000 - $238,000

Please note: the base salary compensation range and actual salary offered to the final candidate depends on various factors: relevant work experience, skills, and years of experience

4DMT provides equal employment opportunities to all employees and applicants for employment without regard to race, color, religion, gender, sexual orientation, national origin, age, disability, genetic information, marital status, status as a covered veteran, and any other category protected under applicable federal, state, provincial and local laws.
 
Equal Opportunity Employer/Protected Veterans/Individuals with Disabilities


Teams

This job is not in any teams